Literature DB >> 30107181

SnapShot: Bladder Cancer.

Carolyn Hurst1, Jonathan Rosenberg2, Margaret Knowles1.   

Abstract

Bladder cancers, the majority of which are urothelial carcinoma, are the most common urinary tract cancers. There are two major disease types, muscle-invasive and non-muscle-invasive, with distinct pathogenesis pathways, molecular features, and clinical outcomes. Recent genomic and transcriptomic data have significantly improved tumor sub-classification and prognostication for both patient groups and are informing improved approaches to treatment of muscle-invasive disease. To view this SnapShot, open or download the PDF.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Year:  2018        PMID: 30107181     DOI: 10.1016/j.ccell.2018.07.013

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  13 in total

1.  Loss of polarity protein Par3, via transcription factor Snail, promotes bladder cancer metastasis.

Authors:  Shenyi Wang; Jinming Cai; Si Zhang; Mingwei Dong; Li Zhang; Yingying Xu; Bing Shen; She Chen
Journal:  Cancer Sci       Date:  2021-05-01       Impact factor: 6.716

Review 2.  Preclinical Models for Bladder Cancer Research.

Authors:  Shaoming Zhu; Zheng Zhu; Ai-Hong Ma; Guru P Sonpavde; Fan Cheng; Chong-Xian Pan
Journal:  Hematol Oncol Clin North Am       Date:  2021-04-16       Impact factor: 2.861

3.  Prognostic value of immune cell infiltration in bladder cancer: A gene expression-based study.

Authors:  Yao Wang; Hong-Jun Ba; Zi-Chuan Liu; Xu-Bin Deng; Min Zhou
Journal:  Oncol Lett       Date:  2020-06-17       Impact factor: 2.967

4.  Alterations in detrusor contractility in rat model of bladder cancer.

Authors:  Igor B Philyppov; Ganna V Sotkis; Aurelien Rock; Morad Roudbaraki; Jean-Louis Bonnal; Brigitte Mauroy; Natalia Prevarskaya; Yaroslav M Shuba
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

5.  Bioinformatic Identification of Potential Hub Genes in Muscle-Invasive Bladder Urothelial Carcinoma.

Authors:  Changgang Guo; Ting Shao; Dadong Wei; Chunsheng Li; Fengjun Liu; Minghui Li; Zhiming Gao; Guochang Bao
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

6.  CircLIFR synergizes with MSH2 to attenuate chemoresistance via MutSα/ATM-p73 axis in bladder cancer.

Authors:  Hui Zhang; Xingyuan Xiao; Wenjie Wei; Chao Huang; Miao Wang; Liang Wang; Yuanqiao He; Jiayin Sun; Yangkai Jiang; Guosong Jiang; Xiaoping Zhang
Journal:  Mol Cancer       Date:  2021-04-19       Impact factor: 27.401

7.  Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosis.

Authors:  Ruiting Ye; Han Zeng; Zhaopei Liu; Kaifeng Jin; Chunnan Liu; Sen Yan; Yanze Yu; Runze You; Hongyi Zhang; Yuan Chang; Yiwei Wang; Li Liu; Yu Zhu; Jiejie Xu; Le Xu; Zewei Wang
Journal:  Cancer Immunol Immunother       Date:  2021-06-21       Impact factor: 6.968

8.  A nomogram combining long non-coding RNA expression profiles and clinical factors predicts survival in patients with bladder cancer.

Authors:  Yifan Wang; Lutao Du; Xuemei Yang; Juan Li; Peilong Li; Yinghui Zhao; Weili Duan; Yingjie Chen; Yunshan Wang; Haiting Mao; Chuanxin Wang
Journal:  Aging (Albany NY)       Date:  2020-02-12       Impact factor: 5.682

9.  The Interplay between Oxidative Phosphorylation and Glycolysis as a Potential Marker of Bladder Cancer Progression.

Authors:  Greta Petrella; Giorgia Ciufolini; Riccardo Vago; Daniel Oscar Cicero
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

10.  Occupational bladder cancer: A cross section survey of previous employments, tasks and exposures matched to cancer phenotypes.

Authors:  Oliver Reed; Ibrahim Jubber; Jon Griffin; Aidan P Noon; Louise Goodwin; Syed Hussain; Marcus G Cumberbatch; James W F Catto
Journal:  PLoS One       Date:  2020-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.